Zuellig to help strengthen Korean drug firms’ presence in overseas markets

Published: 2011-12-26 06:58:00

Updated: 2011-12-26 06:58:00

Zuellig Pharma Korea is planning to support Korean drug makers’ advancement into Asian pharmaceutical markets through Zuellig’s global logistics network, according to Christophe Piganiol, president of Zuellig Pharma Korea.

In a press interview, Piganiol said that Zuellig may help with the pape...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK